Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Log ind
Få fuld adgang
Sox Therapeutics AB
AB
Active
Org 5595265900
Tillverkning av läkemedel
·
NACE 2120
Stiftet 2025 · 1 år gammel
1 ansatte
Overvåg
Del
Sverige
/
Virksomheder
/
Manufacture of pharmaceutical preparations
/
Sox Therapeutics AB
Overblik
Regnskaber
Personer & ejerskab
Relaterede virksomheder
Loading company…
Personer & ejerskab
Ledelse
Nuværende ledelse
Name
Role
Member since
Current (1)
KÅ
Karl Å Fredrik Johansson Swartling
Chief Executive Officer
Chief Executive Officer
2026
Bestyrelse
Bestyrelsestilsyn
Name
Role
Member since
Current (4)
LM
Luis Mateo Santurio Puentes
Board of Directors
Board of Directors
2025
KÅ
Karl Å Fredrik Johansson Swartling
Board of Directors
Board of Directors
2025
NJ
Nils Jan Ragnar Nilsson
Board of Directors
Board of Directors
2026
CE
Christina Elisabeth Herder
Chairman
Chairman
2026
Tidligere (4)
CP
Carl Philip Anders Franzén
Deputy Board Member
Deputy Board Member
2025 – 2025
SM
Stina Maria Selldén
Deputy Board Member
Deputy Board Member
2025 – 2025
EA
Erik Alexander Stötsberg
Aktionærer
Pr. seneste årsrapport
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Mere om Sox Therapeutics AB
Overblik →
Hovedtal, risikovurdering og virksomhedsresumé
Regnskaber & nøgletal →
Omsætning, EBITDA, balance og 5-års udvikling
Relaterede virksomheder →
Koncernstruktur, moder- og datterselskabsnetværk
Deputy Board Member
Deputy Board Member
2025 – 2025
MJ
Mikaela Jenni Berglund
Board of Directors
Board of Directors
2025 – 2025